126 related articles for article (PubMed ID: 27515347)
21. Molecule of the Month. TMC-207.
Drug News Perspect; 2009 Sep; 22(7):421. PubMed ID: 19890499
[No Abstract] [Full Text] [Related]
22. [New antitubercular drugs].
Krasucka-Kluźniak A
Pneumonol Pol; 1990; 58(4-5):163-6. PubMed ID: 2168041
[No Abstract] [Full Text] [Related]
23. [Sensitivity of Mycobacterium tuberculosis in our environment].
Unzaga MJ; Sota M; Melero P; Berdonces P; Ezpeleta C; Cisterna R
Enferm Infecc Microbiol Clin; 1996; 14(6):399-400. PubMed ID: 8756225
[No Abstract] [Full Text] [Related]
24. New drugs for the treatment of Mycobacterium tuberculosis infection.
AlMatar M; AlMandeal H; Var I; Kayar B; Köksal F
Biomed Pharmacother; 2017 Jul; 91():546-558. PubMed ID: 28482292
[TBL] [Abstract][Full Text] [Related]
25. [Primary resistance of Mycobacterium tuberculosis].
Blancarte L; Anzaldo de Jaime G; Balandrano S
Salud Publica Mex; 1982; 24(3):321-7. PubMed ID: 6815813
[No Abstract] [Full Text] [Related]
26. Minimising moxifloxacin resistance with tuberculosis.
Drlica K; Zhao X; Kreiswirth B
Lancet Infect Dis; 2008 May; 8(5):273-5. PubMed ID: 18471768
[No Abstract] [Full Text] [Related]
27. Progress on mechanism of ethambutol resistance in Mycobacterium Tuberculosis.
Wang T; Jiao WW; Shen AD
Yi Chuan; 2016 Oct; 38(10):910-917. PubMed ID: 27806932
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis.
Sharma A; Pandey R; Sharma S; Khuller GK
Int J Antimicrob Agents; 2004 Dec; 24(6):599-604. PubMed ID: 15555884
[TBL] [Abstract][Full Text] [Related]
29. Identification of drug candidates that enhance pyrazinamide activity from a clinical compound library.
Niu H; Ma C; Cui P; Shi W; Zhang S; Feng J; Sullivan D; Zhu B; Zhang W; Zhang Y
Emerg Microbes Infect; 2017 Apr; 6(4):e27. PubMed ID: 28442749
[No Abstract] [Full Text] [Related]
30. Mycobacterium Tuberculosis Biofilm - A new perspective.
Nayak N
Indian J Tuberc; 2015 Jan; 62(1):4-6. PubMed ID: 25857559
[No Abstract] [Full Text] [Related]
31. Reversion of phenotypic fluoroquinolone resistance in Mycobacterium tuberculosis.
Eilertson B; Maruri F; Blackman A; Herrera M; Sterling TR
Int J Tuberc Lung Dis; 2016 Sep; 20(9):1276-7. PubMed ID: 27510259
[No Abstract] [Full Text] [Related]
32. [Signal transduction and drug resistance in Mycobacterium tuberculosis--A review].
Wang S; Feng Y; Zhang Z
Wei Sheng Wu Xue Bao; 2015 Aug; 55(8):971-6. PubMed ID: 26665593
[TBL] [Abstract][Full Text] [Related]
33. Pyrazinamide: a frontline drug used for tuberculosis. Molecular mechanism of action resolved after 50 years?
Kalinda AS; Aldrich CC
ChemMedChem; 2012 Apr; 7(4):558-60. PubMed ID: 22241617
[No Abstract] [Full Text] [Related]
34. [Phage amplified biologically assay and its application in rapid detection of Mycobacterium tuberculosis].
Hu ZY
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):850-2. PubMed ID: 15730788
[No Abstract] [Full Text] [Related]
35. Improving the tuberculosis drug development pipeline.
Evangelopoulos D; McHugh TD
Chem Biol Drug Des; 2015 Nov; 86(5):951-60. PubMed ID: 25772393
[TBL] [Abstract][Full Text] [Related]
36. CDC advises on management of persons exposed to multiple-drug-resistant tuberculosis.
Clin Pharm; 1992 Dec; 11(12):991, 994, 999. PubMed ID: 1337505
[No Abstract] [Full Text] [Related]
37. [Surveillance of resistance of Mycobacterium tuberculosis to anti-TB drugs in Cuba, 1995-1998].
Montoro E; Echemendía M; Lemus D; Marrero A; Llanes MJ; Valdivia JA
Biomedica; 2004 Jun; 24 Supp 1():80-4. PubMed ID: 15495575
[TBL] [Abstract][Full Text] [Related]
38. Could Killing Bacterial Subpopulations Hit Tuberculosis out of the Park?
Baranowski C; Rubin EJ
J Med Chem; 2016 Jul; 59(13):6025-6. PubMed ID: 27322073
[TBL] [Abstract][Full Text] [Related]
39. [Short-term chemotherapy of tuberculosis in Chile. Bacteriological considerations].
Valenzuela P
Rev Med Chil; 1983 Jul; 111(7):747-9. PubMed ID: 6440255
[No Abstract] [Full Text] [Related]
40. [Treatment of drug resistant tuberculosis].
Perel'man MI; Sokolova GB; Borisov SE; Kunichan AD; Lazareva IaV; Mozhokina GN; Elistratova NA; Tsybanev AA
Antibiot Khimioter; 2003; 48(8):28-36. PubMed ID: 14722939
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
